Research
Our research focuses the dissection of mechanisms that underlie response and resistance to immunotherapies and on the longitudinal tracking of tumor cell evolution using single-cell lineage-tracing approaches based on interrogation of natural barcodes like somatic nuclear or mitochondrial DNA mutations.
Highlighted
[no title info]
[no publisher info]
·
[no date info]
·
[no id info]
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Nature Communications
·
02 Jan 2024
·
doi:10.1038/s41467-023-44137-7
Targeted genotyping of scRNA-seq cDNA libraries using long-read sequencing with Oxford Nanopore
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022018246
Single cell RNA sequencing analysis dissecting responses to ipilimumab treatment of relapsed AML/MDS with and without stem cell transplantation.
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History
Cancer Discovery
·
01 Dec 2021
·
doi:10.1158/2159-8290.CD-21-0276
First demonstration that longitudinal changes of mitochondrial DNA mutations reflect therapeutic bottlenecks.
All
2024
Therapy response in AML: a tale of two T cells
Blood
·
12 Sep 2024
·
doi:10.1182/blood.2024024593
Commentary on Mazziotta et al
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Blood Cancer Discovery
·
05 Sep 2024
·
doi:10.1158/2643-3230.BCD-23-0138
Single-cell tracking of clonal evolution and microchimerism using mitochondrial DNA mutations
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Leukemia
·
26 Aug 2024
·
doi:10.1038/s41375-024-02381-w
Immune cell networks in pediatric and adult acute myeloid leukemia
Artifacts in single-cell mitochondrial DNA mutation analyses misinform phylogenetic inference
Cold Spring Harbor Laboratory
·
29 Jul 2024
·
doi:10.1101/2024.07.28.605517
Commentary on problematic analyses of mitochondrial DNA mutations
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice
Journal of Clinical Investigation
·
25 Jun 2024
·
doi:10.1172/JCI177460
TIM-3 inhibition stimulates graft-versus-leukemia responses against AML
Single-cell genomics-based immune and disease monitoring in blood malignancies
Clinical Hematology International
·
14 Jun 2024
·
doi:10.46989/001c.117961
Single-cell genomics-based immune and disease monitoring in blood malignancies
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Nature Communications
·
02 Jan 2024
·
doi:10.1038/s41467-023-44137-7
Targeted genotyping of scRNA-seq cDNA libraries using long-read sequencing with Oxford Nanopore
2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Science Immunology
·
29 Sep 2023
·
doi:10.1126/sciimmunol.adf4968
First demonstration that preexisting tumor-resident T cells associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022018246
Single cell RNA sequencing analysis dissecting responses to ipilimumab treatment of relapsed AML/MDS with and without stem cell transplantation.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022017686
Clinical study of CTLA-4 blockade and decitabine in relapsed AML/MDS with or without stem cell transplantation.
2022
In VivoModeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Blood Cancer Discovery
·
06 Dec 2022
·
doi:10.1158/2643-3230.BCD-22-0082
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models
Cancer Research
·
05 Dec 2022
·
doi:10.1158/0008-5472.CAN-22-0275
First demonstration of mtDNA mutation-based lineage-tracing in murine cancer models.
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
Cancer Immunology Research
·
19 Sep 2022
·
doi:10.1158/2326-6066.CIR-22-0434
AML relapse after a TIGIT race
Blood
·
15 Sep 2022
·
doi:10.1182/blood.2022017614
Comment on Gournay et al. describing post-transplant immune reconstitution dynamics.
Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy
Cytotherapy
·
01 Aug 2022
·
doi:10.1016/j.jcyt.2022.03.005
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
Clinical Cancer Research
·
20 Apr 2022
·
doi:10.1158/1078-0432.CCR-21-2834
Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics
Frontiers in Immunology
·
03 Jan 2022
·
doi:10.3389/fimmu.2021.788891
2021
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History
Cancer Discovery
·
01 Dec 2021
·
doi:10.1158/2159-8290.CD-21-0276
First demonstration that longitudinal changes of mitochondrial DNA mutations reflect therapeutic bottlenecks.
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
Blood Advances
·
18 Nov 2021
·
doi:10.1182/bloodadvances.2021004335
Integrated analysis of exceptional response to PD-1 inhibition in relapsed sAML after allogeneic stem cell transplantation with scRNA-seq, CITE-seq, scATAC-seq and CyTOF.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Blood
·
16 Mar 2021
·
doi:10.1182/blood.2021010867
Dissection of exceptional responses to CTLA-4 blockade in relapsed leukemia cutis after allogeneic stem cell transplantation.
2020
Personal tumor antigens in blood malignancies: genomics-directed identification and targeting
Journal of Clinical Investigation
·
27 Jan 2020
·
doi:10.1172/JCI129209
Review of targets for cellular immunotherapies in blood malignancies.
2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology
·
01 Oct 2019
·
doi:10.1002/eji.201970107
Best practices for flow cytometry.
Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer
OncoImmunology
·
24 Mar 2019
·
doi:10.1080/2162402X.2019.1586409
Phenotypes and T cell receptor sequences of tumor-infiltrating lymphocytes compared to physiologic tissue-resident T cells.
2018
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells
European Journal of Immunology
·
03 Apr 2018
·
doi:10.1002/eji.201847507
Demonstration of the high accuracy of FACS index sorting using single T and B cell receptor sequencing.
2017
Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow
Cancer Immunology Research
·
31 Aug 2017
·
doi:10.1158/2326-6066.cir-17-0012
Identification of myeloma clones in phenotypically healthy B cell compartment using B cell receptor sequencing.
2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Leukemia
·
31 Jul 2015
·
doi:10.1038/leu.2015.212
A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma
Targeted Oncology
·
06 Jan 2015
·
doi:10.1007/s11523-014-0354-5